Search

1 to 10 of 394
Sort by

Library Entry
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy without good treatment options. There are limited data about the use of immunotherapy in ACC. The authors investigated the efficacy and safety of pembrolizumab in patients with metastatic ACC. They concluded that single-agent pembrolizumab has...


Library Entry
Unchecked immunity: a unique case of sequential immune-related adverse events with Pembrolizumab

The authors present a case of sequential immune-related adverse events (irAEs) in a patient with metastatic melanoma treated with single-agent anti-programmed cell death-1 (PD-1) therapy, pembrolizumab. Although numerous cases of irAEs have been reported, sequential multi-organ involvement,...


Library Entry
Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis

Hypophysitis is a well-recognized immune-related adverse event in patients treated with immune checkpoint inhibitors for cancer. Some anterior pituitary hormones may recover; however, secondary adrenal insufficiency is usually permanent. This case documents an unusual recovery from secondary...


Library Entry
Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis

The gut microbiome impacts the efficacy of immune checkpoint inhibitor (ICI) therapy and the development of ICI-mediated diarrhea and / or colitis (IMDC). Antibiotic therapy,especially that with anaerobic activity, has profound effects on the gut microbiome. In this study, the authors sought...


Web Page
Nashville, Tenn. - Webcast

Wednesday, Dec. 4, 2019 4:25 p.m. EST Organizers: Suzanne Jones, PharmD – Sarah Cannon Jeffrey C. Rathmell, PhD – Vanderbilt University School of Medicine Anil Shanker, PhD – Meharry Medical College School of Medicine ACI Live Webcast Registration Information Advanced online...


Library Entry
2018 Advances in Cancer Immunotherapy™ Post Program Webinar Series - Miami Webinar 2

From the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) post-program webinar recording for the Miami event is provided here. The purpose of this...

Advances in Cancer Immunotherapy™ Post-Program Webinar 2 (Miami).mp4


Library Entry
2018 Advances in Cancer Immunotherapy™ Post Program Webinar Series - Miami Webinar 1

From the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) post-program webinar recording for the Miami event is provided here. The purpose of this...

Advances in Cancer Immunotherapy™ Post-Program Webinar 1 (Miami).mp4


Library Entry
2018 Advances in Cancer Immunotherapy™ Post Program Webinar Series - Durham Webinar 1

From the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) post-program webinar recording for the Durham event is provided here. The purpose of...

Advances in Cancer Immunotherapy™ Post-Program Webinar 1 (Durham).mp4


Library Entry
2018 Advances in Cancer Immunotherapy™ Post Program Webinar Series - Dallas Webinar 2

From the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) post-program webinar recording for the Dallas event is provided here. The purpose of...

Advances in Cancer Immunotherapy™ Post-Program Webinar 2 (Dallas).mp4